Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Nat Rev Drug Discov ; 15(6): 369-70, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-27173942

RESUMO

Integrating a wide range of biomedical data such as that rapidly emerging from the use of next-generation sequencing is expected to have a key role in identifying and qualifying new biomarkers to support precision medicine. Here, we highlight some of the challenges for biomedical data integration and approaches to address them.


Assuntos
Biomarcadores/análise , Pesquisa Biomédica , Sequenciamento de Nucleotídeos em Larga Escala/métodos , Informática Médica/métodos , Medicina de Precisão/métodos , Integração de Sistemas , Interpretação Estatística de Dados , Humanos
2.
FASEB J ; 17(3): 376-85, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12631577

RESUMO

Microarray profiles of bulk tumor tissues reflect gene expression corresponding to malignant cells as well as to many different types of contaminating normal cells. In this report, we assess the feasibility of querying baseline multitissue transcriptome databases to dissect disease-specific genes. Using colon cancer as a model tumor, we show that the application of Boolean operators (AND, OR, BUTNOT) for database searches leads to genes with expression patterns of interest. The BUTNOT operator for example allows the assignment of "expression signatures" to normal tissue specimens. These expression signatures were then used to computationally identify contaminating cells within conventionally dissected tissue specimens. The combination of several logic operators together with an expression database based on multiple human tissue specimens can resolve the problem of tissue contamination, revealing novel cancer-specific gene expression. Several markers, previously not known to be colon cancer associated, are provided.


Assuntos
Neoplasias do Colo/genética , Biologia Computacional/métodos , Perfilação da Expressão Gênica , Análise de Sequência com Séries de Oligonucleotídeos , Colo/anatomia & histologia , Colo/metabolismo , Neoplasias do Colo/metabolismo , Humanos , Transcrição Gênica
3.
Cell Syst ; 1(4): 302-305, 2015 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-26594663

RESUMO

Networks are a powerful and flexible methodology for expressing biological knowledge for computation and communication. Network-encoded information can include systematic screens for molecular interactions, biological relationships curated from literature, and outputs from analysis of Big Data. NDEx, the Network Data Exchange (www.ndexbio.org), is an online commons where scientists can upload, share, and publicly distribute networks. Networks in NDEx receive globally unique accession IDs and can be stored for private use, shared in pre-publication collaboration, or released for public access. Standard and novel data formats are accommodated in a flexible storage model. Organizations can use NDEx as a distribution channel for networks they generate or curate. Developers of bioinformatic applications can store and query NDEx networks via a common programmatic interface. NDEx helps expand the role of networks in scientific discourse and facilitates the integration of networks as data in publications. It is a step towards an ecosystem in which networks bearing data, hypotheses, and findings flow easily between scientists.

4.
Artigo em Inglês | MEDLINE | ID: mdl-24303286

RESUMO

tranSMART is an emerging global open source public private partnership community developing a comprehensive informatics-based analysis and data-sharing cloud platform for clinical and translational research. The tranSMART consortium includes pharmaceutical and other companies, not-for-profits, academic entities, patient advocacy groups, and government stakeholders. The tranSMART value proposition relies on the concept that the global community of users, developers, and stakeholders are the best source of innovation for applications and for useful data. Continued development and use of the tranSMART platform will create a means to enable "pre-competitive" data sharing broadly, saving money and, potentially accelerating research translation to cures. Significant transformative effects of tranSMART includes 1) allowing for all its user community to benefit from experts globally, 2) capturing the best of innovation in analytic tools, 3) a growing 'big data' resource, 4) convergent standards, and 5) new informatics-enabled translational science in the pharma, academic, and not-for-profit sectors.

5.
Drug Discov Today ; 18(9-10): 428-34, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23247259

RESUMO

Research in the life sciences requires ready access to primary data, derived information and relevant knowledge from a multitude of sources. Integration and interoperability of such resources are crucial for sharing content across research domains relevant to the life sciences. In this article we present a perspective review of data integration with emphasis on a semantics driven approach to data integration that pushes content into a shared infrastructure, reduces data redundancy and clarifies any inconsistencies. This enables much improved access to life science data from numerous primary sources. The Semantic Enrichment of the Scientific Literature (SESL) pilot project demonstrates feasibility for using already available open semantic web standards and technologies to integrate public and proprietary data resources, which span structured and unstructured content. This has been accomplished through a precompetitive consortium, which provides a cost effective approach for numerous stakeholders to work together to solve common problems.


Assuntos
Coleta de Dados , Disseminação de Informação , Armazenamento e Recuperação da Informação , Integração de Sistemas , Disciplinas das Ciências Biológicas , Humanos , Internet
6.
Drug Discov Today ; 16(21-22): 940-7, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21963522

RESUMO

The life science industries (including pharmaceuticals, agrochemicals and consumer goods) are exploring new business models for research and development that focus on external partnerships. In parallel, there is a desire to make better use of data obtained from sources such as human clinical samples to inform and support early research programmes. Success in both areas depends upon the successful integration of heterogeneous data from multiple providers and scientific domains, something that is already a major challenge within the industry. This issue is exacerbated by the absence of agreed standards that unambiguously identify the entities, processes and observations within experimental results. In this article we highlight the risks to future productivity that are associated with incomplete biological and chemical vocabularies and suggest a new model to address this long-standing issue.


Assuntos
Pesquisa Biomédica/métodos , Descoberta de Drogas/métodos , Indústria Farmacêutica/normas , Terminologia como Assunto , Pesquisa Biomédica/normas , Comportamento Cooperativo , Bases de Dados Factuais , Humanos , Vocabulário
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA